Skip to main content
. 2012 Sep 15;28(3):385–398. doi: 10.1007/s00384-012-1551-2

Table 5.

Summary of Ki-67 measurements

Treated with 5-FU Treated with sorafenib N Mean Standard deviation Minimum Lower quartile Median Upper quartile Maximum
No No 5 48.9 3.3 44.3 47 49.7 51.7 52
Yes 5 34.5 4.8 28 33 33.7 37.3 40.7
Yes No 5 36.5 5.3 29.7 34.3 35 40 43.3
Yes 6 37.3 7 28.5 34 36.7 38 49.7